Honeywell International Inc. (ETR:ALD)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	119,715	141,876	125,076	134,814	126,217	122,011
Market Cap Growth	-1.80%	13.43%	-7.22%	6.81%	3.45%	8.26%
Enterprise Value	143,559	162,768	137,668	144,744	135,366	128,744
Last Close Price	189.06	216.68	183.43	189.71	170.71	155.99
PE Ratio	24.59	25.75	24.44	29.01	25.90	31.23
PS Ratio	3.52	3.82	3.77	4.06	4.17	4.57
PB Ratio	8.44	7.67	8.41	8.32	7.46	8.39
P/FCF Ratio	-	29.78	32.14	31.96	27.91	28.15
P/OCF Ratio	-	24.09	25.89	27.32	23.77	24.04
EV/Sales Ratio	4.14	4.38	4.15	4.36	4.48	4.83
EV/EBITDA Ratio	16.07	17.58	17.43	18.70	17.70	20.57
EV/EBIT Ratio	19.47	20.43	20.14	21.88	20.60	23.67
EV/FCF Ratio	33.94	34.16	35.38	34.32	29.93	29.70
Debt / Equity Ratio	2.26	1.68	1.31	1.19	1.07	1.30
Debt / EBITDA Ratio	3.67	3.27	2.40	2.41	2.30	2.94
Debt / FCF Ratio	7.58	6.53	5.01	4.56	4.01	4.38
Asset Turnover	0.54	0.56	0.59	0.56	0.53	0.53
Inventory Turnover	3.71	3.78	3.93	4.19	4.58	4.98
Quick Ratio	0.91	0.89	0.85	0.89	0.95	1.16
Current Ratio	1.29	1.31	1.27	1.25	1.30	1.47
Return on Equity (ROE)	33.60%	32.25%	33.60%	27.16%	30.29%	26.65%
Return on Assets (ROA)	7.15%	7.54%	7.63%	6.97%	7.24%	6.75%
Return on Capital (ROIC)	10.47%	11.54%	12.45%	11.37%	11.55%	10.88%
Return on Capital Employed (ROCE)	14.90%	15.30%	17.60%	16.70%	16.60%	14.70%
Earnings Yield	4.07%	3.88%	4.09%	3.45%	3.86%	3.20%
FCF Yield	3.53%	3.36%	3.11%	3.13%	3.58%	3.55%
Dividend Yield	2.19%	1.95%	2.06%	1.96%	1.94%	1.90%
Payout Ratio	51.34%	50.87%	50.46%	54.75%	47.38%	54.24%
Buyback Yield / Dilution	1.41%	1.93%	2.18%	2.47%	1.52%	2.61%
Total Shareholder Return	3.60%	3.88%	4.24%	4.43%	3.46%	4.52%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.